Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by James George and Sara Vesely.

 
Connection Strength
 
 
 
12.020
 
  1. George JN, Vesely SK. A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion. 2012 Jul; 52(7):1593-4; author reply 1594-5.
    View in: PubMed
    Score: 0.569
  2. George JN, Terrell DR, Swisher KK, Vesely SK. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23(4):129-37.
    View in: PubMed
    Score: 0.417
  3. George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
    View in: PubMed
    Score: 0.369
  4. Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004 Aug; 44(8):1149-58.
    View in: PubMed
    Score: 0.329
  5. George JN, Vesely SK. How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7.
    View in: PubMed
    Score: 0.321
  6. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20.
    View in: PubMed
    Score: 0.317
  7. George JN, Vesely SK. Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5.
    View in: PubMed
    Score: 0.309
  8. George JN, Vesely SK. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3.
    View in: PubMed
    Score: 0.296
  9. Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866.
    View in: PubMed
    Score: 0.238
  10. Reese JA, Peck JD, Yu Z, Scordino TA, Deschamps DR, McIntosh JJ, Terrell DR, Vesely SK, George JN. Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol. 2019 01; 94(1):E8-E11.
    View in: PubMed
    Score: 0.221
  11. Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, Vesely SK, George JN. Platelet Counts during Pregnancy. N Engl J Med. 2018 Jul 05; 379(1):32-43.
    View in: PubMed
    Score: 0.216
  12. Ayanambakkam A, Kremer Hovinga JA, Vesely SK, George JN. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646.
    View in: PubMed
    Score: 0.204
  13. Reese JA, Peck JD, McIntosh JJ, Vesely SK, George JN. Platelet counts in women with normal pregnancies: A systematic review. Am J Hematol. 2017 Nov; 92(11):1224-1232.
    View in: PubMed
    Score: 0.203
  14. Page EE, Little DJ, Vesely SK, George JN. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
    View in: PubMed
    Score: 0.203
  15. Uhl L, Kiss JE, Malynn E, Terrell DR, Vesely SK, George JN. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
    View in: PubMed
    Score: 0.201
  16. Little DJ, Mathias LM, Page EE, Kremer Hovinga JA, Vesely SK, George JN. Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura. Kidney Int Rep. 2017 Nov; 2(6):1088-1095.
    View in: PubMed
    Score: 0.201
  17. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv. 2017 Apr 11; 1(10):590-600.
    View in: PubMed
    Score: 0.198
  18. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2016 10 27; 128(17):2175-2178.
    View in: PubMed
    Score: 0.191
  19. Terrell DR, Reese J, Branesky D, Lu K, Watson SI, Thachil J, Vesely SK, George JN. Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3.
    View in: PubMed
    Score: 0.189
  20. Page EE, Jiang Y, Terrell DR, Vesely SK, George JN. Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9.
    View in: PubMed
    Score: 0.187
  21. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
    View in: PubMed
    Score: 0.185
  22. Liles NW, Page EE, Liles AL, Vesely SK, Raskob GE, George JN. Diversity and severity of adverse reactions to quinine: A systematic review. Am J Hematol. 2016 May; 91(5):461-6.
    View in: PubMed
    Score: 0.185
  23. Han B, Page EE, Stewart LM, Deford CC, Scott JG, Schwartz LH, Perdue JJ, Terrell DR, Vesely SK, George JN. Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14.
    View in: PubMed
    Score: 0.174
  24. Reese JA, Bougie DW, Curtis BR, Terrell DR, Vesely SK, Aster RH, George JN. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015 May; 90(5):406-10.
    View in: PubMed
    Score: 0.171
  25. Lim W, Vesely SK, George JN. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31.
    View in: PubMed
    Score: 0.170
  26. McClain RS, Terrell DR, Vesely SK, George JN. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9.
    View in: PubMed
    Score: 0.168
  27. Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8.
    View in: PubMed
    Score: 0.168
  28. Little DJ, Reese JA, Vesely SK, George JN. Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8.
    View in: PubMed
    Score: 0.162
  29. Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80.
    View in: PubMed
    Score: 0.158
  30. Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN. Drug-induced thrombocytopenia in children. Pediatr Blood Cancer. 2013 Dec; 60(12):1975-81.
    View in: PubMed
    Score: 0.154
  31. Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142.
    View in: PubMed
    Score: 0.153
  32. Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82.
    View in: PubMed
    Score: 0.152
  33. George JN, Vesely SK, Woolf SH. Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
    View in: PubMed
    Score: 0.150
  34. George JN, Vesely SK, Terrell DR, Deford CC, Reese JA, Al-Nouri ZL, Stewart LM, Lu KH, Muthurajah DS. The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care. Hamostaseologie. 2013 May 29; 33(2):105-12.
    View in: PubMed
    Score: 0.148
  35. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7.
    View in: PubMed
    Score: 0.142
  36. Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
    View in: PubMed
    Score: 0.142
  37. Som S, Deford CC, Kaiser ML, Terrell DR, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
    View in: PubMed
    Score: 0.140
  38. George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med. 2012 Mar; 41(3 Pt 2):e177-88.
    View in: PubMed
    Score: 0.138
  39. Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51.
    View in: PubMed
    Score: 0.134
  40. Terrell DR, Motto DG, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43.
    View in: PubMed
    Score: 0.131
  41. Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010 Nov; 85(11):844-7.
    View in: PubMed
    Score: 0.127
  42. Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010 Sep 23; 116(12):2127-33.
    View in: PubMed
    Score: 0.123
  43. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
    View in: PubMed
    Score: 0.121
  44. Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb 25; 115(8):1500-11; quiz 1662.
    View in: PubMed
    Score: 0.120
  45. Benjamin M, Terrell DR, Vesely SK, Voskuhl GW, Dezube BJ, Kremer Hovinga JA, Lämmle B, George JN. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37.
    View in: PubMed
    Score: 0.114
  46. Kennedy AS, Lewis QF, Scott JG, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101.
    View in: PubMed
    Score: 0.113
  47. Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 2009 May; 49(5):873-87.
    View in: PubMed
    Score: 0.112
  48. Nguyen L, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4.
    View in: PubMed
    Score: 0.112
  49. Swisher KK, Li X, Vesely SK, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf. 2009; 32(1):85-6.
    View in: PubMed
    Score: 0.112
  50. Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24.
    View in: PubMed
    Score: 0.110
  51. Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lämmle B, Vesely SK, George JN. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707.
    View in: PubMed
    Score: 0.106
  52. George JN, Kremer Hovinga JA, Terrell DR, Vesely SK, Lämmle B. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008 Apr; 80(4):277-86.
    View in: PubMed
    Score: 0.105
  53. Ambadwar P, Duvall D, Wolf NJ, Terrell DR, Vesely SK, George JN. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher. 2008; 23(5):168-9.
    View in: PubMed
    Score: 0.104
  54. Hawkins BM, Abu-Fadel M, Vesely SK, George JN. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion. 2008 Feb; 48(2):382-92.
    View in: PubMed
    Score: 0.103
  55. Nguyen L, Li X, Duvall D, Terrell DR, Vesely SK, George JN. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57.
    View in: PubMed
    Score: 0.103
  56. Karpac CA, Lee A, Kunnel BS, Bamgbola OF, Vesely SK, George JN. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33.
    View in: PubMed
    Score: 0.103
  57. Swisher KK, Doan JT, Vesely SK, Kwaan HC, Kim B, Lämmle B, Kremer Hovinga JA, George JN. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica. 2007 Jul; 92(7):936-43.
    View in: PubMed
    Score: 0.101
  58. Johnson KK, Duvall D, Gilcher RO, Smith JW, Forsberg JE, Terrell DR, Vesely SK, George JN. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8.
    View in: PubMed
    Score: 0.101
  59. George JN, Vesely SK, James JA. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J. 2007 May; 100(5):512-4.
    View in: PubMed
    Score: 0.099
  60. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9.
    View in: PubMed
    Score: 0.097
  61. Li X, Swisher KK, Vesely SK, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf. 2007; 30(2):185-6.
    View in: PubMed
    Score: 0.097
  62. Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006 Jan; 46(1):154-6.
    View in: PubMed
    Score: 0.091
  63. Terrell DR, Johnson KK, Vesely SK, George JN. Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9.
    View in: PubMed
    Score: 0.085
  64. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34.
    View in: PubMed
    Score: 0.082
  65. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004 Feb; 44(2):294-304.
    View in: PubMed
    Score: 0.079
  66. George JN, Vesely SK, Terrell DR. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
    View in: PubMed
    Score: 0.079
  67. George JN, Raskob GE, Vesely SK, Moore D, Lyons RM, Cobos E, Towell BL, Klug P, Guthrie TH. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
    View in: PubMed
    Score: 0.078
  68. Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8.
    View in: PubMed
    Score: 0.075
  69. McMinn JR, Thomas IA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion. 2003 Mar; 43(3):415-6.
    View in: PubMed
    Score: 0.075
  70. Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, Kühne T. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
    View in: PubMed
    Score: 0.074
  71. Howard MA, Hibbard AB, Terrell DR, Medina PJ, Vesely SK, George JN. Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent). 2003 Jan; 16(1):21-6.
    View in: PubMed
    Score: 0.074
  72. van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115.
    View in: PubMed
    Score: 0.056
  73. Pishko AM, Misgav M, Cuker A, Cines DB, George JN, Vesely SK, Terrell DR. Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
    View in: PubMed
    Score: 0.054
  74. Edgar CE, Terrell DR, Vesely SK, Wren JD, Dozmorov IM, Niewold TB, Brown M, Zhou F, Frank MB, Merrill JT, Kremer Hovinga JA, Lämmle B, James JA, George JN, Farris AD. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614.
    View in: PubMed
    Score: 0.043
  75. Lu KH, George JN, Vesely SK, Terrell DR. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
    View in: PubMed
    Score: 0.040
  76. Nokes T, George JN, Vesely SK, Awab A. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63.
    View in: PubMed
    Score: 0.039
  77. Griffin D, Al-Nouri ZL, Muthurajah D, Ross JR, Ballard RB, Terrell DR, Vesely SK, George JN, Marques MB. First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion. 2013 Jan; 53(1):235-7.
    View in: PubMed
    Score: 0.037
  78. Froehlich-Zahnd R, George JN, Vesely SK, Terrell DR, Aboulfatova K, Dong JF, Luken BM, Voorberg J, Budde U, Sulzer I, Lämmle B, Kremer Hovinga JA. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2012 Feb; 97(2):297-303.
    View in: PubMed
    Score: 0.034
  79. Newton JL, Reese JA, Watson SI, Vesely SK, Bolton-Maggs PH, George JN, Terrell DR. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
    View in: PubMed
    Score: 0.033
  80. Guidry JA, Watson S, George JN, Vesely SK, Terrell DR. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
    View in: PubMed
    Score: 0.029
  81. Terrell DR, Beebe LA, George JN, Vesely SK, Mold JW. Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood. 2009 Apr 23; 113(17):4126-7.
    View in: PubMed
    Score: 0.029
  82. Guidry JA, George JN, Vesely SK, Kennison SM, Terrell DR. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
    View in: PubMed
    Score: 0.028
  83. Howard MA, Duvall D, Terrell DR, Christopher AT, Thomas I, Holloway N, Vesely SK, George JN. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.